Kawasaki disease in Greek children: A retrospective study

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 5, 2013, Pages 580-588

  Alexopoulos, A ^a   Vekiou, A ^a   Lycopoulou, L ^a   Tavena, A ^a   Lagona, E ^a   Kakourou, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; IMMUNOGLOBULIN; INFLIXIMAB; METHYLPREDNISOLONE; SODIUM;

ARTICLE; CERVICAL LYMPHADENOPATHY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONJUNCTIVA DISEASE; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE COURSE; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FOLLOW UP; GREECE; HOSPITAL DISCHARGE; HUMAN; INFANT; LABORATORY TEST; LEUKOCYTE COUNT; LIMB INJURY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SEASONAL VARIATION; SPRING; SUMMER; THROMBOCYTE COUNT; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL; CHILD; CHILD, PRESCHOOL; FEMALE; GREECE; HUMANS; INFANT; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; SEASONS;

EID: 84876145746     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04488.x     Document Type: Article

References (37)

1. Newburger JW, Fulton DR,. Kawasaki disease. Curr Opin Pediatr 2004; 16: 508-514.
2. Kawasaki T,. 1967 Acute febrile mucocutaneous syndrome with lymphoid involve- ment with specific desquamation of the fingers and toes in children. Pediatr Infect Dis J 2002; 21 (11): 993-995.
3. Yanagisawa M, Kobayashi N, Matsuya S,. Myocardial infarction due to coronary thromboarteritis, following acute febrile mucocutaneous lymph node syndrome (MLNS) in an infant. Pediatrics 1974; 54: 277-280.
4. Kato H, Koike S, Yamamoto M, et al. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 1975; 86: 892-898.
5. Yanagawa H, Nakamura Y, Kawasaki T, et al. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-1986. Lancet 1986; 2: 1138-1139.
6. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome in Hawaii. Pediatr Infect Dis J 2005; 24: 429-433.
7. Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics 1989; 84: 666-669.
8. Burns JC, Shimizu C, Gonzalez E, et al. Genetic variations in the receptor- ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki Disease. J Infect Dis 2005; 192: 344-349.
9. Rowley AH,. Incomplete (atypical) Kawasaki disease. Pediatr Infect Dis J 2002; 21: 563-565.
10. Wu CY, Hsieh KS, Chiou YH, et al. Prolonged fever and pyuria: a urinary tract infection presentation of incomplete Kawasaki disease. Acta Paediatr 2005; 94: 375-377.
11. Chang CH, Chen MH, Yang W,. Kawasaki disease presenting with lymphadenopathy and gastrointestinal hemorrhage: report of one case. Acta Paediatr Taiwan 2004; 45: 171-173.
12. Duzova A, Topaloglu R, Keskin M, et al. An unusual pattern of arthritis in a child with Kawasaki syndrome. Clin Rheumatol 2004; 23: 73-75.
13. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Pediatrics 2004; 114: 1708-33. 110: 2741-71.
14. Hashino K, Ishii M, Iemura M, et al. Re-treatment for immuneglobulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 2001; 43: 211-217.
15. Royle J, Burgner D, Curtis N,. The diagnosis and management of Kawasaki disease. J Paediatr Child Health 2005; 41: 87-93.
16. Taubert KA,. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997; 6: 181-185.
17. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol 2008; 18: 167-172.
18. Sinan Mahir Kayiran, Aygun Dindar, Berkan Guraken,. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study. Clinics 2010; 65: 1261-1265.
19. Burns JC, Glode MP,. Kawasaki syndrome. Lancet 2004; 364: 533-544.
20. Chang RK,. Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics 2002; 109: e87.
21. Kuniyuki S, Asada M,. An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol 1997; 37: 303-304.
22. Lee KY, Han JW, Hong JH, et al. Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory profiles according to duration of fever. J Korean Med Sci 2004; 19: 501-504.
23. Mitani Y, Sawada H, Hayakawa H, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 2005; 111: 38-43.
24. Iwashima S, Kimura M, Ishikawa T, et al. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study. Clin Drug Investig 2011; 31: 191-199.
25. Mine K, Takaya J, Hasui M, et al. A case of Kawasaki disease associated with syndrome of inappropriate secretion of antidiuretic hormone. Acta Paediatr 2004; 93: 1547-1549.
26. Harnden A, Takahashi M, Burgner D,. Kawasaki disease. BMJ 2009; 338: b1514. doi: 10.1136/bmj.b1514.
27. Manlhiot C, Yeung RS, Clarizia NA, et al. Kawasaki disease at the extremes of the age spectrum. Pediatrics. 2009; 124: e410-e415. Epub 24 August 2009
28. Song D, Yeo Y, Ha K, et al. Risk factors for KD, associated coronary abnormalities differ depending on age. Eur J Pediatr 2009; 168: 1315-1321.
29. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-1639.
30. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, et al. Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale andmechanisms of action. Nat Clin Pract Rheumatol 2007; 3: 262-272.
31. Heaton P, Wilson N, Nicholson R, et al. Kawasaki disease in New Zealand. J Paediatr Child Health 2006; 42: 184-190.
32. Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128: 146-149.
33. Furukawa T, Kishiro M, Akimoto K, et al. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease. Arch Dis Child 2008; 93: 142-146.
34. Burns JC, Mason WH, Hauger SB, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005; 146: 662-667.
35. Burns JC, Best BM, Mejias A, et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr 2008; 153: 833-838.
36. Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible KD. United States multicenter KD study group. J Pediatr 1991; 118: 680-686.
37. Hsieh KS, Weng KP, Lin CC, et al. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics 2004; 114: 689-693.